Echo Therapeutics Inc (NASDAQ:ECTE)

Data as of 11:54am ET
 +0.04 / +1.98%
Today’s Change
Today|||52-Week Range
Health Technology
Medical Specialties

Company Description

Echo Therapeutics, Inc. is a transdermal medical device company with significant expertise in advanced skin permeation technology. The company is involved in developing Prelude SkinPrep System, which is a platform technology to allow painless skin permeation that would enable both needle-free drug delivery and analyte extraction; and Symphony CGM System, a non-invasive, wireless, and transdermal continuous glucose monitoring system for use in hospital critical care units and for patients with diabetes. It also engages in the development of specialty pharmaceuticals based on its proprietary AzoneTS transdermal drug reformulation technology. The company's drug candidate is Durhalieve, an AzoneTS formulation of triamcinolone acetonide for the treatment of corticosteroid-responsive dermatoses. Echo Therapeutics was founded on September 14, 2007 and is headquartered in Philadelphia, PA.

Contact Information

Echo Therapeutics, Inc.
8 Penn Center
Philadelphia Pennsylvania 19103
P:(215) 717-4100
Investor Relations:
(215) 717-4104



Other institutional25.38%
Mutual fund holders2.26%
Individual stakeholders19.01%

Top Executives

Scott Wayne HollanderPresident, Chief Executive Officer & Director
Thomas H. BishopVice President-Operations & Product Development
Alan Wayne SchoenbartChief Financial Officer & Secretary
Kenneth GarySenior Vice President-Research & Development
Mary McNamara-CullinaneVice President-Regulatory & Clinical Affairs

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2015 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2015. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2015 and/or its affiliates.